Metformin modulates FJX1 via upregulation of Hsa-miR-1306-3p to suppress colon adenocarcinoma viability

Dong, Y. et al. The development and benefits of metformin in various diseases. Front. Med. 17, 388–431 (2023).

Article 
PubMed 
MATH 

Google Scholar 

Lv, Z. & Guo, Y. Metformin and its benefits for various diseases. Front. Endocrinol. (Lausanne) 11, 191 (2020).

Article 
PubMed 
MATH 

Google Scholar 

Kaneto, H., Kimura, T., Obata, A., Shimoda, M. & Kaku, K. Multifaceted mechanisms of action of metformin which have been unraveled one after another in the long history. Int. J. Mol. Sci. 22, 2596 (2021).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Skuli, S. J. et al. Metformin and cancer, an ambiguanidous relationship. Pharmaceuticals (Basel) 15, 626 (2022).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Bray, F. et al. Global cancer statistics 2022: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229–263 (2024).

Article 
PubMed 
MATH 

Google Scholar 

Tarhini, Z. et al. The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus. Sci. Rep. 12, 12374 (2022).

Article 
ADS 
CAS 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Sugiura, K. et al. Metformin inhibits the development and metastasis of colorectal cancer. Med. Oncol. 39, 136 (2022).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Wang, Q. & Shi, M. Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: A meta-analysis. Anticancer Drugs 33, 191–199 (2022).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Sawicki, T. et al. A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers (Basel) 13, 2025 (2021).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Taieb, J. et al. Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment. Eur. J. Cancer 175, 136–157 (2022).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Hamdy, N. M. et al. Unraveling the ncRNA landscape that governs colorectal cancer: A roadmap to personalized therapeutics. Life Sci. 354, 122946 (2024).

Article 
CAS 
PubMed 

Google Scholar 

Rizk, N. I. et al. Revealing the role of serum exosomal novel long non-coding RNA NAMPT-AS as a promising diagnostic/prognostic biomarker in colorectal cancer patients. Life Sci. 352, 122850 (2024).

Article 
CAS 
PubMed 

Google Scholar 

Ng, C. W. et al. Metformin and colorectal cancer: A systematic review, meta-analysis and meta-regression. Int. J. Colorectal Dis. 35, 1501–1512 (2020).

Article 
PubMed 
MATH 

Google Scholar 

Lee, J. W. et al. Metformin usage and the risk of colorectal cancer: A national cohort study. Int. J. Colorectal Dis. 36, 303–310 (2021).

Article 
PubMed 
MATH 

Google Scholar 

Dukes, C. E. The classification of cancer of the rectum. J. Pathol. Bacteriol. 35, 323–332 (1932).

Article 
MATH 

Google Scholar 

Puppa, G., Sonzogni, A., Colombari, R. & Pelosi, G. TNM staging system of colorectal carcinoma: A critical appraisal of challenging issues. Arch. Pathol. Lab. Med. 134, 837–852 (2010).

Article 
PubMed 

Google Scholar 

Geh, I. et al. Association of coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the management of cancer of the colon, rectum and anus (2017)—Anal cancer. Colorectal Dis. 19(Suppl 1), 82–97 (2017).

Article 
PubMed 

Google Scholar 

Amin, M. B. et al. The eighth edition AJCC cancer staging manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J. Clin. 67, 93–99 (2017).

Article 
PubMed 
MATH 

Google Scholar 

Argiles, G. et al. Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 31, 1291–1305 (2020).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Glynne-Jones, R. et al. Rectal cancer: ESMO Clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 29, iv263 (2018).

Article 
CAS 
PubMed 

Google Scholar 

Chen, K., Collins, G., Wang, H. & Toh, J. W. T. Pathological features and prognostication in colorectal cancer. Curr. Oncol. 28, 5356–5383 (2021).

Article 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Delattre, J. F. et al. A comprehensive overview of tumour deposits in colorectal cancer: Towards a next TNM classification. Cancer Treat. Rev. 103, 102325 (2022).

Article 
PubMed 
MATH 

Google Scholar 

Akkoca, A. N. et al. TNM and modified dukes staging along with the demographic characteristics of patients with colorectal carcinoma. Int. J. Clin. Exp. Med. 7, 2828–2835 (2014).

PubMed 
PubMed Central 
MATH 

Google Scholar 

Eldosoky, M. A. et al. Diagnostic significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p panel and ratios in hepatocellular carcinoma on top of liver cirrhosis in HCV-infected patients. Int. J. Mol. Sci. 24, 3157 (2023).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Macfarlane, L. A. & Murphy, P. R. MicroRNA: Biogenesis, function and role in cancer. Curr. Genomics 11, 537–561 (2010).

Article 
CAS 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Hamdy, N. M. et al. Advancements in current one-size-fits-all therapies compared to future treatment innovations for better improved chemotherapeutic outcomes: A step-toward personalized medicine. Curr. Med. Res. Opin. 40, 1943–1961 (2024).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

He, B. et al. miRNA-based biomarkers, therapies, and resistance in cancer. Int. J. Biol. Sci. 16, 2628–2647 (2020).

Article 
CAS 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Hill, M. & Tran, N. miRNA interplay: Mechanisms and consequences in cancer. Dis. Model Mech. 14, dmm047662 (2021).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Segal, M. & Slack, F. J. Challenges identifying efficacious miRNA therapeutics for cancer. Expert. Opin. Drug. Discov. 15, 987–992 (2020).

Article 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Nangia-Makker, P. et al. Metformin: A potential therapeutic agent for recurrent colon cancer. PLoS One 9, e84369 (2014).

Article 
ADS 
PubMed 
PubMed Central 

Google Scholar 

Zhang, Y., Chen, R., Deng, L., Shuai, Z. & Chen, M. The effect of metformin on the proliferation, apoptosis and CD133 mRNA expression of colon cancer stem cells by upregulation of miR 342–3p. Drug Des. Devel. Ther. 15, 4633–4647 (2021).

Article 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Hong, X. L. et al. Metformin abrogates FUSOBACTERIUM nucleatum-induced chemoresistance in colorectal cancer by inhibiting miR-361-5p/sonic hedgehog signaling-regulated stemness. Br. J. Cancer 128, 363–374 (2023).

Article 
CAS 
PubMed 

Google Scholar 

Saini, N. & Yang, X. Metformin as an anti-cancer agent: Actions and mechanisms targeting cancer stem cells. Acta Biochim. Biophys. Sin. (Shanghai) 50, 133–143 (2018).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Saito, A. et al. Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus. Cancer Sci. 111, 4012–4020 (2020).

Article 
CAS 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Kamarudin, M. N. A., Sarker, M. M. R., Zhou, J. R. & Parhar, I. Metformin in colorectal cancer: Molecular mechanism, preclinical and clinical aspects. J. Exp. Clin. Cancer Res. 38, 491 (2019).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Lu, G. et al. The effects of metformin on autophagy. Biomed. Pharmacother. 137, 111286 (2021).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Niu, L. et al. Biological implications and clinical potential of metastasis-related miRNA in colorectal cancer. Mol. Ther. Nucleic Acids 23, 42–54 (2021).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Zhang, N., Hu, X., Du, Y. & Du, J. The role of miRNAs in colorectal cancer progression and chemoradiotherapy. Biomed. Pharmacother. 134, 111099 (2021).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Saberinia, A., Alinezhad, A., Jafari, F., Soltany, S. & Akhavan Sigari, R. Oncogenic miRNAs and target therapies in colorectal cancer. Clin. Chim. Acta 508, 77–91 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Pichler, M. et al. MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients. Br. J. Cancer 110, 1614–1621 (2014).

Article 
CAS 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Mogavero, A. et al. Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production. Sci. Rep. 7, 15992 (2017).

Article 
ADS 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Wang, Y., Wu, Z. & Hu, L. The regulatory effects of metformin on the [SNAIL/miR-34]:[ZEB/miR-200] System in the epithelial-mesenchymal transition (EMT) for colorectal cancer (CRC). Eur. J. Pharmacol. 834, 45–53 (2018).

Article 
CAS 
PubMed 

Google Scholar 

Wang, Z. et al. Identification of potential diagnostic and prognostic biomarkers for colorectal cancer based on GEO and TCGA databases. Front. Genet. 11, 602922 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Bu, T. et al. Regulation of sertoli cell function by planar cell polarity (PCP) protein Fjx1. Mol. Cell. Endocrinol. 571, 111936 (2023).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Huang, M. et al. Comprehensive analysis of the prognosis and immune effect of the oncogenic protein four jointed box 1. Front. Oncol. 13, 1170482 (2023).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Al-Greene, N. T. et al. Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma. PLoS One 8, e69660 (2013).

Article 
ADS 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Zou, J. et al. Multi-omics analysis of the tumor microenvironment in liver metastasis of colorectal cancer identified FJX1 as a novel biomarker. Front. Genet. 13, 960954 (2022).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Liu, L. et al. FJX1 as a candidate diagnostic and prognostic serum biomarker for colorectal cancer. Clin. Transl. Oncol. 24, 1964–1974 (2022).

Article 
CAS 
PubMed 
MATH 

Google Scholar 

Cheng, T., Zhu, X., Lu, J. & Teng, X. MiR-532-3p suppresses cell proliferation, migration and invasion of colon adenocarcinoma via targeting FJX1. Pathol. Res. Pract. 232, 153835 (2022).

Article 
CAS 
PubMed 

Google Scholar 

Dang, W. & Zhu, Z. MicroRNA-1249 targets four-jointed box kinase 1 and reduces cell proliferation, migration and invasion of colon adenocarcinoma. J. Gene. Med. 22, e3183 (2020).

Article 
CAS 
PubMed 

Google Scholar 

Pan, Y., Zhang, Y., Hu, X. & Li, S. Construction of a novel cuproptosis-related ceRNA network-SNHG3/miR-1306-5p/PDHA1 and identification of SNHG3 as a prognostic biomarker in hepatocellular carcinoma. ACS Omega 8, 38690–38703 (2023).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Dang, Y. et al. lncRNA AC007207.2 promotes malignant properties of osteosarcoma via the miR-1306–5p/SIRT7 axis. Cancer Manag. Res. 13, 7277–7288 (2021).

Article 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Liu, W. et al. Identifying a novel IRF3/circUHRF1/miR-1306-5p/ARL4C axis in pancreatic ductal adenocarcinoma progression. Cell Cycle 21, 392–405 (2022).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Wang, W., Zhang, J., Fan, Y. & Zhang, L. MiR-1306-5p predicts favorable prognosis and inhibits proliferation, migration, and invasion of colorectal cancer cells via PI3K/AKT/mTOR pathway. Cell Cycle 21, 1491–1501 (2022).

Article 
CAS 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Trotta, E. On the normalization of the minimum free energy of RNAs by sequence length. PLoS One 9, e113380 (2014).

Article 
ADS 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Coronel-Hernandez, J. et al. Combination of metformin, sodium oxamate and doxorubicin induces apoptosis and autophagy in colorectal cancer cells via downregulation HIF-1alpha. Front. Oncol. 11, 594200 (2021).

Article 
CAS 
PubMed 
PubMed Central 

Google Scholar 

Orang, A. et al. A functional screen with metformin identifies MicroRNAs that regulate metabolism in colorectal cancer cells. Sci. Rep. 12, 2889 (2022).

Article 
ADS 
CAS 
PubMed 
PubMed Central 
MATH 

Google Scholar 

Sevim, C. et al. Investigation of the effects of metformin on the miR-21/PTEN/Akt pathway in HT-29 human colorectal adenocarcinoma cell and huvec co-culture. Cancer 72, 1 (2024).

MATH 

Google Scholar 

Chen, Y. C. et al. Effect of vitamin D supplementation on primary dysmenorrhea: A systematic review and meta-analysis of randomized clinical trials. Nutrients 15, 2830 (2023).

Article 
CAS 
PubMed 
PubMed Central 
MATH 

Google Scholar